Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Ousted BARDA Director Bright Says Hydroxychloroquine EUA Distracted From Coronavirus Work

May 15 2020

• By Derrick Gingery

Rick Bright faces Commerce Health Subcommittee with his lawyer Debra Katz on 14 May 2020 — Rick Bright faces the House Commerce Health Subcommittee with his lawyer Debra Katz on 14 May 2020. • Source: Screenshot of hearing broadcast

Related Content

Republicans Favor Regulatory ‘Leeway’ On Drug Use During Emergencies, Bright Hearing Shows

May 15 2020

Woodcock Said To Have Guided Hydroxychloroquine EUA In ‘Brokered Compromise’ To Limit Use

May 06 2020

US FDA Safety Alert For Hydroxychloroquine Is Latest Turn In Drug's Strange Journey

Apr 27 2020

FDA's Emergency Use Authorization for Malaria Drugs Could Hinder Trials of Other COVID-19 Treatments

Mar 31 2020

White House Hypes Chloroquine, A Drug Currently In Shortage, As Coronavirus Treatment Hope

Mar 20 2020

Related Companies

Pfizer Inc.

Teva Pharmaceutical Industries Ltd.

Additional Topics

United States Coronavirus COVID-19 FDA Politics Regulation BioPharmaceutical Infectious Diseases

More from US FDA

More from Agency Leadership

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window